Search for: "NOVARTIS PHARMACEUTICALS CORP." Results 201 - 220 of 367
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Apr 2013, 1:01 pm by Bexis
A lot of things happened last week – so much that our usual wrap-up search last Friday took over three hours, which is more than twice as long as normal. [read post]
2 Dec 2011, 2:00 pm by Bexis
Novartis Pharmaceuticals Corp., ___ Fed. [read post]
14 Dec 2007, 1:00 am
: (Patent Prospector)  PharmaAggregate launches new online presence: (MaRS Blog - Innovation and Commercialization in Canada)Japan Plans Generic Drug Incentives to Cut Down Medical Costs: (MedIndia), Interesting commentary and article on generic/ innovator company patent settlements: (Generic Pharmaceuticals & IP), Global trends in commencement of patent actions by innovators: (Generic Pharmaceuticals & IP), Is… [read post]
12 Mar 2012, 5:41 pm by FDABlog HPM
Novartis Pharmaceuticals Corp., No. 33-av-00001 (D.N.J., Mar. 7, 2012) (Complaint) Plumbers and Pipefitters Local 572 Health and Welfare Fund v. [read post]
2 Nov 2007, 11:00 pm
: (PLI), (PatentDocs), (Patent Baristas), (Patently'O), Vonage settles patent dispure with Verizon: (IP Law360), Celgene and Novartis file extended release Ritalin suit: (IP Law360), T-Mobile USA is the latest to settle charges that it infringed technology for computerized sales methods held by patent-holding company Orion IP LLC: (IP Law360),Bayer beats Dr Reddy's on Avelox (moxifloxacin): (OrangeBookBlog), (Generic Pharmaceuticals), Martek obtains permanent injunction… [read post]
23 Aug 2016, 10:34 am by Lawrence B. Ebert
” Appellee Br.at 7 n.3 (citing Novartis Pharmaceuticals Corp. v. [read post]
7 Sep 2010, 6:10 pm by Kelly
Perrigo Co (IPBiz) Norvir (Ritonavir) – US: Abbott’s HIV/AIDS drug patents challenged by PUBPAT (IP Watchdog) ReFacto (Moroctocog) and Xyntha (Antihemophilic factor) – US: Novartis drops one of three patents from ReFacto/Xyntha suit against Wyeth (Patent Docs) Strattera (Atomoxetine) – US: CAFC grants injunction pending disposition of Lilly v Actavis Elizabeth (Patent Docs) Valcyte (Valganciclovir) – US: Ranbaxy settles patent dispute with Roche over Valcyte… [read post]
8 Dec 2007, 11:00 am
: (IP Think Tank), WIPO - Idris gets paid out to leave early: (IAM), (Patent Prospector), Deutsche Grammophon ditches DRM: (ArsTechnica)PharmaFDA revisits NCE exclusivity for enantiomers: (Arnall Golden & Gregory), Accupril (Quinapril) - Judge finds against Teva and holds Warner-Lambert patent enabled: (IPLaw360), (OrangeBookBlog), Altace / Tritace / Ramace (Ramipril) - King Pharmaceuticals loses CAFC rehearing bid: (IPLaw360), … [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram)… [read post]
14 Aug 2009, 1:04 am
Novartis Pharmaceuticals Corp., 2009 WL 2230471, at *7 (S.D. [read post]